Virtual Tumor Board: Gastrointestinal Cancer-July 2020

Activity Overview

In this tumor board, participants will learn through case-based discussions about:

Data regarding the optimal multidisciplinary treatment regimen for patients with potentially curable gastroesphageal junction.
Data regarding the management of patients with pathogenic CDH1 gene mutations (Hereditary Diffuse Gastric Cancer).
Relevance of MSI status and the presence of other targetable mutations in the treatment of locally advanced gastric cancer.

The moderator is Kaitlyn Kelly, MD, UCSD Moores Cancer Center.

Panelists include: Daniel Coit, MD, Memorial Sloan Kettering Cancer Center; Vivian Strong, MD, Memorial Sloan Kettering Cancer Center; Laleh Melstrom, MD, City of Hope; Daniel Simpson, MD, UCSD Moores Cancer Center, and Gregory Botta, UCSD Moores Cancer Center.

Summary


Cost:	FREE


Credit Offered:	No Credit Offered